|
Adjustments to Final Inpatient Rule Offer Benefits to Devicemakers
Devicemakers, which have been bracing themselves for the Centers for Medicare & Medicaid Services (CMS) proposal to cut reimbursement rates under Medicare’s inpatient prospective payment system (IPPS), can relax a bit.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives